Glial fibrillary acidic protein

There are 277 papers on glial fibrillary acidic protein in aging research: 16 trials and 200 observational studies in people, 31 in animals, 2 in cells, 25 reviews. The newest story, Nov 5, 2026: “Brain structure linked to disrupted sleep in older adults”.

Biomarker

277 papers study it440 more mention it101 findings

MeSH

25 new papers in 30 daysSee all 717 papers on glial fibrillary acidic protein

At a glance

Higher glial fibrillary acidic protein is linked with greater dementia risk and slower gait in human cohorts. Mortality associations vary: cohorts report higher risk, while a study in community-dwelling older adults finds no clear link with cardiovascular events or death. A human trial reports lower levels with hearing aids in people with untreated hearing loss.

101 findings in 87 papers from 2009 to 2026, 16 of them since April 2026

“Plasma biomarkers were associated with cognitive outcomes but not depressive symptoms.”
Plasma GFAP modifies the association of depressive symptoms with cognitive function: A population-based studyAlzheimer's & dementia : the journal of the Alzheimer's Association2026doi:10.1002/alz.71761
  • Human trial16
  • Humans200
  • Animals31
  • Cells2
  • In silico1

Interventions

14

Marine omega-3 fatty acids

downin humans1

1 study
  1. Marine omega-3 fatty acids decrease glial fibrillary acidic protein in humans Among Black participants (-12.4% (95% CI: −21.5% to −2.2%)).

    Human trialAmong Black participants4‐year

  2. Marine omega-3 fatty acids decrease glial fibrillary acidic protein in Black participants (-12.4% (95% CI: -21.5% to -2.2%)).

    Human trialin Black participantsplasma1 g/day4 years

More on Marine omega-3 fatty acids

Childhood poverty

no changein humans1

1 study
  1. Childhood poverty was not clearly linked with glial fibrillary acidic protein in humans.

    Humansn = 5,473

More on Childhood poverty

Female sex

upin humans1

1 study
  1. Female sex is linked with higher glial fibrillary acidic protein in humans (female compared with male participants) (median 6.17 pg/mL higher in female than male participants).

    Humansfemale compared with male participantsfemales

More on Female sex

Hearing aids

downin humans1

1 study
  1. Hearing aids decrease glial fibrillary acidic protein in ARIC participants with untreated hearing loss (mean -0.415 (95% CI -0.712, -0.118)).

    Human trialin ARIC participants with untreated hearing loss3 yearsn = 164

More on Hearing aids

DPP-4 inhibitors

no changein humans1

1 study
  1. DPP-4 inhibitors were not clearly linked with glial fibrillary acidic protein in older adults with type 2 diabetes.

    Humansin older adults with type 2 diabetesplasma18 monthsn = 43

More on DPP-4 inhibitors

Insulin

downin humans1

1 study
  1. Insulin decreases glial fibrillary acidic protein in humans.

    Human trialintranasal40 IU q.i.d.4 weeks

More on Insulin

Blood pressure variability + arterial stiffness

no changein humans1

1 study
  1. Blood pressure variability + arterial stiffness was not clearly linked with glial fibrillary acidic protein in humans (without major neurological or systemic disease).

    Humanswithout major neurological or systemic diseaseplasman = 105

More on Blood pressure variability + arterial stiffness

Racial discrimination

no changein humans1

1 study
  1. Racial discrimination was not clearly linked with glial fibrillary acidic protein in humans.

    Humans

More on Racial discrimination

Exercise

no changein humans1

1 study
  1. Exercise showed no clear effect on glial fibrillary acidic protein in humans.

    Human trial26 daysn = 22

More on Exercise

Head-down tilt bed rest

upin humans1

1 study
  1. Head-down tilt bed rest increases glial fibrillary acidic protein in humans.

    Human trial26 daysn = 22

More on Head-down tilt bed rest

All 14

Effects

9

Cognitive function

downin humans1no changein humans1

2 studies
  1. Glial fibrillary acidic protein is linked with worse cognitive function in humans (adjusted for demographics) (P < 0.05).

    Humansadjusted for demographicsplasman = 491

  2. Glial fibrillary acidic protein was not clearly linked with cognitive function in humans.

    Humanssurvey-weighted linear regression adjusted for sociodemographic, cardiometabolic, kidney and APOE ε4 covariatesn = 5,730

Longitudinal orthostatic blood pressure changes

no changein humans1

1 study
  1. Glial fibrillary acidic protein was not clearly linked with longitudinal orthostatic blood pressure changes in humans (Baseline GFAP categories dichotomized at 142.515 pg/mL).

    HumansBaseline GFAP categories dichotomized at 142.515 pg/mL15 years62% womensn = 1,492

    Alzheimer’s blood marker linked to standing blood pressure drops

    ESC Congress 2026 abstract

Cardiovascular events and death

no changein humans1

1 study
  1. Glial fibrillary acidic protein was not clearly linked with cardiovascular events and death in humans (Community-dwelling older adults).

    HumansCommunity-dwelling older adultsplasmaMedian follow-up of 10 yearsn = 806

    Nerve injury marker linked to death in community-living 75-year-olds

    European heart journal open

Gait speed

downin humans1

1 study
  1. Glial fibrillary acidic protein is linked with lower gait speed in humans (highest vs lowest quartile) (β: -0.007, 95% CI: -0.013; -0.002).

    Humanshighest vs lowest quartile15 yearsn = 1,665

    Alzheimer’s blood markers linked to faster walking-speed decline

    Journal of cachexia, sarcopenia and muscle

Sustained attention

no changein humans1

1 study
  1. Glial fibrillary acidic protein was not clearly linked with sustained attention in humans (cognitively unimpaired).

    Humanscognitively unimpairedn = 146

    Brain and blood measures linked to attention in older adults

    bioRxiv : the preprint server for biologyPreprint

Vessel skeleton density

no changein humans1

1 study
  1. Glial fibrillary acidic protein was not clearly linked with vessel skeleton density in humans.

    Humans

More on Vessel skeleton density

Executive function

downin humans1−62% higher odds of cognitive impairment

1 study
  1. Glial fibrillary acidic protein is linked with worse executive function in humans (Uganda Aging Cohort Study) (62% higher odds of cognitive impairment).

    HumansUganda Aging Cohort Studyplasman = 560

Gait velocity

downin humans1

1 study
  1. Glial fibrillary acidic protein is linked with worse gait velocity in humans (adjusted for age, sex, BMI, Charlson Comorbidity Index, and cognitive diagnosis) (-2.100 cm/sec per SD (95% CI: -3.004, -1.196)).

    Humansadjusted for age, sex, BMI, Charlson Comorbidity Index, and cognitive diagnosisplasman = 2,641

Chair stand test performance

downin humans1

1 study
  1. Glial fibrillary acidic protein is linked with worse chair stand test performance in humans (dementia-free) (β 0.38, 95% CI 0.22;0.54).

    Humansdementia-free12-yearn = 2,011

Upstream

15

Autosomal dominant Alzheimer's disease

upin humans1

1 study
  1. Autosomal dominant Alzheimer's disease is linked with higher glial fibrillary acidic protein in humans (carriers relative to non-carriers).

    Humanscarriers relative to non-carriersplasma14 years before expected symptom onset

More on Autosomal dominant Alzheimer's disease

APOE

upin humans1

1 study
  1. APOE is linked with higher glial fibrillary acidic protein in Hispanics/Latinos.

    Humansin Hispanics/Latinos

More on APOE

Relative amplitude

downin humans1

1 study
  1. Relative amplitude is linked with lower glial fibrillary acidic protein in humans (β=-164.3, p = 0.02).

    Humans64.4%womensn = 180

More on Relative amplitude

Platelet aggregation

no changein humans1

1 study
  1. Platelet aggregation was not clearly linked with glial fibrillary acidic protein in humans.

    Humansserumn = 101

Amyloid-beta 1-40

upin humans1

1 study
  1. Amyloid-beta 1-40 is linked with higher glial fibrillary acidic protein in humans.

    Humansn = 729

More on Amyloid-beta 1-40

Blood pressure variability

no changein humans1

1 study
  1. Blood pressure variability was not clearly linked with glial fibrillary acidic protein in humans.

    Humansn = 105

More on Blood pressure variability

CRP methylation

downin humans1

1 study
  1. CRP methylation is linked with lower glial fibrillary acidic protein in humans (β = -0.076, p = 0.027).

    Humansn = 305

More on CRP methylation

IL-1β

downin humans1

1 study
  1. IL-1β is linked with lower glial fibrillary acidic protein in humans (β = -0.031, p = 0.009).

    Humansn = 305

More on IL-1β

TNF-alpha

downin humans1

1 study
  1. TNF-alpha is linked with lower glial fibrillary acidic protein in humans (β = -0.026, p = 0.008).

    Humansn = 305

More on TNF-alpha

High-sensitivity cardiac troponin T

no changein humans1

1 study
  1. High-sensitivity cardiac troponin T was not clearly linked with glial fibrillary acidic protein in humans.

    Humansserumn = 844

More on High-sensitivity cardiac troponin T

All 15

Associations

50

Cognitive function

downin humans3mixedin humans1

4 studies
  1. Glial fibrillary acidic protein is associated with cognitive function in humans.

    Humansn = 11,059

  2. Glial fibrillary acidic protein is associated with cognitive function in humans (adjusted for age, sex, education, habitat, and comorbidities) (β = -1.68 × 10−3, p = 0.005).

    Humansadjusted for age, sex, education, habitat, and comorbiditiesn = 1,181

  3. Glial fibrillary acidic protein is associated with cognitive function in MDD (R = -0.52, p = 0.014).

    Humansin MDDplasma

  4. Glial fibrillary acidic protein is associated with cognitive function in older people living with HIV.

    Reviewin older people living with HIV

Age

upin humans3+2.7% per year

3 studies
  1. Age is associated with glial fibrillary acidic protein in humans (2.69% per year).

    Humansblood

  2. Age is associated with glial fibrillary acidic protein in humans (Spearman's rho=0.55, p<0.001).

    Humansn = 340

  3. Age is associated with glial fibrillary acidic protein in humans (healthy controls).

    Humanshealthy controls

Mortality

upin humans2mixedin humans1HR 1.43–2.76

3 studies
  1. Glial fibrillary acidic protein is associated with mortality in persons with chronic coronary syndrome; depending on ApoE ε4 genotype.

    Humansin persons with chronic coronary syndrome; depending on ApoE ε4 genotypen = 379

  2. Glial fibrillary acidic protein is linked with a higher risk of mortality in humans (fivefold higher concentrations) (HR 1.43, 95% CI 1.08–1.90).

    Humansfivefold higher concentrationsn = 1,327

  3. Glial fibrillary acidic protein is linked with a higher risk of mortality in humans (highest versus lowest tertile, adjusted models) (HR 2.76 (1.73-4.40)).

    Humanshighest versus lowest tertile, adjusted modelsserum19-yearn = 1,712

Dementia

upin humans3OR 7.52

3 studies
  1. Glial fibrillary acidic protein is linked with a higher risk of dementia in humans (RRR=2.35, 95% CI: 1.22,4.53).

    Humansplasmamedian follow-up of 6.5 years61% femalesn = 919

  2. Glial fibrillary acidic protein is linked with a higher risk of dementia in combination with subjective complaints (OR 7.52; 95%CI 2.79-20.29, p-value < 0.0001).

    Humansin combination with subjective complaints

  3. Glial fibrillary acidic protein is linked with a higher risk of dementia in humans (highest versus lowest tertile, adjusted models) (HR 1.38 (1.15-1.66)).

    Humanshighest versus lowest tertile, adjusted modelsserum19-yearn = 1,712

More on Dementia

Cortical thickness

downin humans2

2 studies
  1. Glial fibrillary acidic protein is associated with cortical thickness in humans (adjusted for demographics, lifestyle, cardiovascular factors, APOE ε4).

    Humansadjusted for demographics, lifestyle, cardiovascular factors, APOE ε4

  2. Glial fibrillary acidic protein is associated with cortical thickness in humans.

    Humansbrain

More on Cortical thickness

Alzheimer's disease

upin humans2HR 1.72

2 studies
  1. Alzheimer's disease is associated with glial fibrillary acidic protein in Down syndrome preclinical AD staging.

    Humansin Down syndrome preclinical AD staging

  2. Glial fibrillary acidic protein is associated with Alzheimer's disease in humans (Baseline concentration standardized as a covariate-adjusted z-score) (HR 1.72; 95% CI 1.63–1.82).

    HumansBaseline concentration standardized as a covariate-adjusted z-scoreplasma

More on Alzheimer's disease

p-tau217-positive/amyloid PET-negative status

upin humans1

1 study
  1. p-tau217-positive/amyloid PET-negative status is associated with glial fibrillary acidic protein in humans (Cognitively normal participants; p-tau+/PET- versus p-tau-/PET-).

    HumansCognitively normal participants; p-tau+/PET- versus p-tau-/PET-plasma

    Mismatched Alzheimer's tests linked to distinct risk patterns

    Alzheimer's & dementia : the journal of the Alzheimer's Association

More on p-tau217-positive/amyloid PET-negative status

Alternative Mediterranean diet

downin humans1

1 study
  1. Alternative Mediterranean diet is associated with glial fibrillary acidic protein in humans (beta -0.018 (95% CI -0.030, -0.006)).

    Humansquantile regression at the median of each biomarker distribution, adjusted for sociodemographic and lifestyle factors1 standard deviation increment in adherencen = 1,769

More on Alternative Mediterranean diet

Loneliness

upin humans1

1 study
  1. Loneliness is associated with glial fibrillary acidic protein in humans (Persistent loneliness) (β 0.16).

    HumansPersistent lonelinessplasman = 3,862

    Social isolation linked to blood marker of nerve-cell injury

    medRxiv : the preprint server for health sciencesPreprint

More on Loneliness

Social isolation

downin humans1

1 study
  1. Social isolation is associated with glial fibrillary acidic protein in humans (Persistent severe social isolation) (β -0.31).

    HumansPersistent severe social isolationplasman = 3,862

    Social isolation linked to blood marker of nerve-cell injury

    medRxiv : the preprint server for health sciencesPreprint

More on Social isolation

All 50

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    Human studies associate glial fibrillary acidic protein with cognitive function and slower gait; plasma levels are higher in autosomal dominant Alzheimer's disease carriers 14 years before expected symptom onset. A human trial finds that marine omega-3 fatty acids at 1 g/day for four years lower plasma levels in Black participants.

  2. Summary written from the findings.

Latest

Dec 2025: 101Jan 2026: 34Feb 2026: 23Mar 2026: 33Apr 2026: 19May 2026: 21Jun 2026: 18Jul 2026: 20Aug 2026: 28Sep 2026: 18Oct 2026: 18Nov 2026: 12345 papers in 12 months
Alzheimer's & Dementia

Brain structure linked to disrupted sleep in older adults

An observational study of 39 older adults without cognitive impairment linked a measure of less complex nerve-cell branching to shorter, more fragmented sleep.An observational study of 39 older adults without cognitive impairment linked a measure of less complex nerve-cell branching to shorter, more fragmented sleep.

Cross-sectional · 39 peopleSleep disruption
ESC Congress 2026 Abstract

Alzheimer’s blood marker linked to standing blood pressure drops

In a 15-year study of 1,492 older adults, an elevated Alzheimer’s-related blood marker tracked with progressively larger blood pressure drops upon standing.In a 15-year study of 1,492 older adults, an elevated Alzheimer’s-related blood marker tracked with progressively larger blood pressure drops upon standing.

Cohort · 1,492 peoplePopulations
European Heart Journal Open

Nerve injury marker linked to death in community-living 75-year-olds

Each doubling of the marker’s blood level was linked to higher mortality, with an adjusted hazard ratio—a relative-risk measure—of 1.91.Each doubling of the marker’s blood level was linked to higher mortality, with an adjusted hazard ratio—a relative-risk measure—of 1.91.

Cohort · 806 peopleBiomarkers
Alzheimer's & Dementia

Mismatched Alzheimer's tests linked to distinct risk patterns

An observational analysis of 594 and 475 cognitively normal adults found different blood-protein patterns depending on which Alzheimer's test was positive.An observational analysis of 594 and 475 cognitively normal adults found different blood-protein patterns depending on which Alzheimer's test was positive.

Cohort · 332 peopleBiomarkers
medRxiv

Nerve-cell injury marker linked to death risk at ages 92–107

Higher marker levels were linked to higher mortality, with reported hazard ratios (relative death-rate measures) of 1.21 to 1.38 across three cohorts.Higher marker levels were linked to higher mortality, with reported hazard ratios (relative death-rate measures) of 1.21 to 1.38 across three cohorts.

Preprint: cohort · 559 peopleBiomarkers

See all 717 papers on glial fibrillary acidic protein